Federal Institute for Drugs and Medical Devices (BfArM)

New Capabilities

As of August 2026: Runs Germany's reimbursed app pathway

People with multiple sclerosis often lose ground on the things drugs don't fix: mood, daily function, the feel of a life worth living. A German trial now reports that a prescribed app, used alongside standard care, measurably improved that quality of life.

Updated Aug 13